ATE271392T1 - Lipoproteinkomplexe und zusammensetzungen, die diese enthalten - Google Patents

Lipoproteinkomplexe und zusammensetzungen, die diese enthalten

Info

Publication number
ATE271392T1
ATE271392T1 AT00903602T AT00903602T ATE271392T1 AT E271392 T1 ATE271392 T1 AT E271392T1 AT 00903602 T AT00903602 T AT 00903602T AT 00903602 T AT00903602 T AT 00903602T AT E271392 T1 ATE271392 T1 AT E271392T1
Authority
AT
Austria
Prior art keywords
complexes
compositions containing
compositions
containing same
lipoprotein complexes
Prior art date
Application number
AT00903602T
Other languages
English (en)
Inventor
Benvenuto Cestaro
Elvira Pistolesi
Original Assignee
Hunza Di Pistolesi Elvira & C
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT1999MI000114 external-priority patent/IT1307917B1/it
Priority claimed from IT99MI002471 external-priority patent/IT1313688B1/it
Application filed by Hunza Di Pistolesi Elvira & C filed Critical Hunza Di Pistolesi Elvira & C
Application granted granted Critical
Publication of ATE271392T1 publication Critical patent/ATE271392T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/005—Enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J7/00—Phosphatide compositions for foodstuffs, e.g. lecithin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Peptides Or Proteins (AREA)
AT00903602T 1999-01-22 2000-01-21 Lipoproteinkomplexe und zusammensetzungen, die diese enthalten ATE271392T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT1999MI000114 IT1307917B1 (it) 1999-01-22 1999-01-22 Complessi lipoproteici e composizioni che li contengono.
IT99MI002471 IT1313688B1 (it) 1999-11-26 1999-11-26 Complessi lipoproteici e composizioni che li contengono.
PCT/EP2000/000452 WO2000043036A2 (en) 1999-01-22 2000-01-21 Lipoprotein complexes and compositions containing them

Publications (1)

Publication Number Publication Date
ATE271392T1 true ATE271392T1 (de) 2004-08-15

Family

ID=26331634

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00903602T ATE271392T1 (de) 1999-01-22 2000-01-21 Lipoproteinkomplexe und zusammensetzungen, die diese enthalten

Country Status (9)

Country Link
US (1) US6340669B1 (de)
EP (1) EP1143999B1 (de)
JP (1) JP2002535288A (de)
KR (1) KR20010101594A (de)
AT (1) ATE271392T1 (de)
AU (1) AU2542500A (de)
CA (1) CA2360065A1 (de)
DE (1) DE60012301D1 (de)
WO (1) WO2000043036A2 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6936289B2 (en) 1995-06-07 2005-08-30 Danisco A/S Method of improving the properties of a flour dough, a flour dough improving composition and improved food products
CN1136007C (zh) 1995-09-06 2004-01-28 协和发酵工业株式会社 脂质代谢改善剂
GB9921229D0 (en) * 1999-09-08 1999-11-10 Med Eq As Compositions
WO2001032038A1 (en) * 1999-10-29 2001-05-10 Hunza Di Pistolesi Elvira E C. S.A.S. Fibrous-liponutritional complexes and compositions containing them
PL204443B1 (pl) 2000-07-28 2010-01-29 Hoffmann La Roche Kompozycja farmaceutyczna zawierająca inhibitor lipazy, sposób wytwarzania kompozycji farmaceutycznej, zestaw do leczenia otyłości, zastosowanie kompozycji farmaceutycznej oraz zastosowanie orlistatu i substancji wiążącej kwasy żółciowe
IT1320180B1 (it) * 2000-12-29 2003-11-26 Hunza Di Marazzita Maria Carme Preparazioni nutrizionali e terapeutiche dotate di attivita'antiossidante ed in grado di controllare gli eccessi ponderali e
ITMI20010141A1 (it) * 2001-01-26 2002-07-26 Giuliani Spa Procedimento per la preparazione di composizioni farmaceutiche o dietetiche per la veicolazione nell'intestino di sostanze labili
NZ528260A (en) 2001-05-18 2005-09-30 Danisco Method of improving dough and bread quality with the addition of an enzyme that hydrolyses a glycolipid and a phospholipid and incapable of hydrolysing a triglyceride or monoglyceride
US6797287B2 (en) * 2001-09-25 2004-09-28 Pharmachem Laboratories, Inc. Phaseolamin compositions and methods for using the same
US20030165574A1 (en) * 2002-03-01 2003-09-04 Ward Loren Spencer Compositions and methods for treatment of body weight conditions
US7790670B2 (en) * 2002-03-01 2010-09-07 Glanbia Nutritionals (Ireland) Ltd. Compositions and methods for treatment of body weight conditions
CA2490079A1 (en) * 2002-06-28 2004-01-08 Pharmachem Laboratories, Inc. Purified amylase inhibitor and novel process for obtaining the same
US7108869B2 (en) * 2002-11-07 2006-09-19 Access Business Group International Llc Nutritional supplement containing alpha-glucosidase and alpha-amylase inhibitors
BRPI0508181A (pt) * 2004-04-02 2007-08-07 Univ Tennessee Res Foundation componentes de laticìnio eficazes para a perda de gordura
US20050244367A1 (en) * 2004-05-03 2005-11-03 Ilypsa, Inc. Phospholipase inhibitors localized in the gastrointestinal lumen
WO2006008508A1 (en) 2004-07-16 2006-01-26 Danisco A/S Enzymatic oil-degumming method
US20090053199A1 (en) * 2005-04-11 2009-02-26 Zemel Michael B Stable Dairy Components Effective for Fat Loss
AU2007330345A1 (en) * 2006-12-07 2008-06-12 Ben-Bar Technology 2006 Mixture and method for reducing cholesterol using hydrophobic chitosan microparticles
US10117885B2 (en) * 2011-08-11 2018-11-06 Allergy Research Group, Llc Chewable lipid supplements for treating pain and fibromyalgia
US9290752B2 (en) 2013-03-13 2016-03-22 Sunny Delight Beverages Co. Process for enhancing the amylase inhibitory efficacy from phaseolus vulgaris extracts

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2400518A1 (de) * 1974-01-07 1975-07-10 Ritter & Co D Diaetetische zubereitung
JP2960947B2 (ja) 1989-12-25 1999-10-12 日清製粉株式会社 脂質分解酵素阻害剤
JPH03291229A (ja) * 1990-04-06 1991-12-20 Kyodo Nyugyo Kk アミラーゼインヒビターによる肥満の治療及びその予防法
CA2128044C (en) 1993-08-05 2007-02-20 Klaus-Dieter Bremer Pharmaceutical compositions comprising a glucosidase and/or amylase inhibitor, and a lipase inhibitor
DE29708250U1 (de) * 1997-05-07 1997-07-10 Lucas Meyer GmbH & Co, 20539 Hamburg Brotaufstrich mit cholesterinspiegelsenkender Wirkung

Also Published As

Publication number Publication date
JP2002535288A (ja) 2002-10-22
WO2000043036A3 (en) 2001-11-01
US6340669B1 (en) 2002-01-22
EP1143999A3 (de) 2002-09-11
EP1143999B1 (de) 2004-07-21
DE60012301D1 (de) 2004-08-26
WO2000043036A2 (en) 2000-07-27
EP1143999A2 (de) 2001-10-17
CA2360065A1 (en) 2000-07-27
KR20010101594A (ko) 2001-11-14
AU2542500A (en) 2000-08-07

Similar Documents

Publication Publication Date Title
ATE271392T1 (de) Lipoproteinkomplexe und zusammensetzungen, die diese enthalten
BR0112094A (pt) Produtos de confeitaria contendo ingredientes ativos
FR2754820B1 (fr) Le (-)hydroxycitrate de magnesium, procede de preparation, applications, et compositions notamment pharmaceutiques le renfermant
HUP9901144A2 (hu) Hatóanyagként klopidogrel és egy antitrombotikum új kombinációját tartalmazó gyógyszerkészítmények
FR2805465B1 (fr) Nouvelles compositions pharmaceutique ou dietetiques a base de champignons
EE04046B1 (et) Vitamiini D ja kaltsiumit sisaldav ravimkoostis, selle valmistamine ja terapeutiline kasutamine
HK1083296A1 (en) Enteral composition for the prevention and/or treatment of sepsis
ID28598A (id) Komposisi-komposisi yang mengandung vitamin-vitamin yang dapat larut lemak
CY1108138T1 (el) Χρησιμοποιηση λουπινοκονγλουτινης δια την θεραπευτικη αγωγη διαβητου τυπου ιι
AU1275401A (en) Fibrous-liponutritional complexes and compositions containing them
ES2195902T3 (es) Composicion que comprende esfingomielinasa alcalina para uso como preparacion dietetica, complemento alimenticio o producto farmaceutico.
BRPI0309421A8 (pt) Método de preparar um gênero alimentício e composição para tratar ou prevenir hipercolesterolemia
CA2388910A1 (en) Antimicrobial activity of the first cationic cluster of human lactoferrin
TR200003737T1 (tr) Diyet takviyesi ya da ilaç olarak kullanılan bileşim
AU5634500A (en) Dietary calcium as a supplement to vitamin d compound treatment of multiple sclerosis
MXPA02011465A (es) Sal de creatina que tiene eficacia terapeutica y nutricional mejorada y composiciones que contienen la misma.
ATE381944T1 (de) Injizierbare arzneimittel die ein anthracendionderivat, mit antitumoraktivität, enthalten
ZA9711734B (en) Novel farnesyl transferase inhibitors, their preparation, the pharmaceutical compositions which contain them and their use in the preparation of medicaments.
AU5284999A (en) New injectable formulations containing ramoplanin
DK1497250T3 (da) Hyperforinderivater, anvendelse heraf og sammensætninger indeholdende disse
BR0001144B1 (pt) Composicão farmacêutica de diclofenaco à base de vitamina-e, papaína e hialuronidase
UA32262A (uk) Зубна паста
EP1498145A4 (de) LOCKSTOFF ZUR BEHANDLUNG UND/ODER PRÄVENTION VON Th2 CYTOKIN-ASSOZIIERTEN ALLERGISCHEN ERKRANKUNGEN, GATA3 MUTANT-PROTEIN UND DIESES ENTHALTENDE MEDIZINISCHE ZUSAMMENSETZUNGEN
ITMI990597A0 (it) Composizioni farmaceutiche dietetiche o alimenti funzionali ad attivita' antiossidante
ITMI981512A0 (it) Composizioni farmaceutiche dietetiche o alimenti funzionali ad attivita' antiossidante

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties